These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2413990)
1. Induction of thymidine kinase activity in a spontaneously enzyme-deficient murine tumor cell line by exposure in vivo to the DNA-hypomethylating agent 5-aza-2'-deoxycytidine: implications for mechanisms of tumor progression. Liteplo RG; Alvarez E; Frost P; Kerbel RS Cancer Res; 1985 Nov; 45(11 Pt 1):5294-8. PubMed ID: 2413990 [TBL] [Abstract][Full Text] [Related]
3. Periodate-oxidized adenosine induction of murine thymidine kinase: role of DNA methylation in the generation of tumor cell heterogeneity. Liteplo RG; Kerbel RS Cancer Res; 1986 Feb; 46(2):577-82. PubMed ID: 3000579 [TBL] [Abstract][Full Text] [Related]
4. Increased sensitivity of nontumorigenic fibroblasts expressing ras or myc oncogenes to malignant transformation induced by 5-aza-2'-deoxycytidine. Rimoldi D; Srikantan V; Wilson VL; Bassin RH; Samid D Cancer Res; 1991 Jan; 51(1):324-30. PubMed ID: 1703037 [TBL] [Abstract][Full Text] [Related]
5. Evidence for allelic exclusion in Chinese hamster ovary cells. Holliday R; Ho T New Biol; 1990 Aug; 2(8):719-26. PubMed ID: 1704254 [TBL] [Abstract][Full Text] [Related]
6. Effect of 5-azacytidine and congeners on DNA methylation and expression of deoxycytidine kinase in the human lymphoid cell lines CCRF/CEM/0 and CCRF/CEM/dCk-1. Antonsson BE; Avramis VI; Nyce J; Holcenberg JS Cancer Res; 1987 Jul; 47(14):3672-8. PubMed ID: 2439195 [TBL] [Abstract][Full Text] [Related]
7. On the possible contribution of DNA hypomethylation to the induction of high frequency and heritable drug-induced alterations in the malignant phenotype. Kerbel RS; Liteplo R; Frost P Prog Clin Biol Res; 1986; 212():293-304. PubMed ID: 2424028 [TBL] [Abstract][Full Text] [Related]
8. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine. Kong XB; Tong WP; Chou TC Mol Pharmacol; 1991 Feb; 39(2):250-7. PubMed ID: 1705001 [TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity of thymidine kinase-deficient (TK-) tumor cell lines to the cell growth inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds. Balzarini J; De Clercq E; Verbruggen A; Crumpacker C; Ayusawa D; Seno T Anticancer Res; 1986; 6(5):1077-84. PubMed ID: 2432829 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines. Bender CM; Pao MM; Jones PA Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064 [TBL] [Abstract][Full Text] [Related]
11. In vivo demethylation of a MoMuLV retroviral vector expressing the herpes simplex thymidine kinase suicide gene by 5' azacytidine. Di Ianni M; Terenzi A; Di Florio S; Venditti G; Benedetti R; Santucci A; Bartoli A; Fettucciari K; Marconi P; Rossi R; Martelli MF; Tabilio A Stem Cells; 2000; 18(6):415-21. PubMed ID: 11072029 [TBL] [Abstract][Full Text] [Related]
12. Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice. Veselý J; Cihák A Cancer Res; 1977 Oct; 37(10):3684-9. PubMed ID: 71199 [TBL] [Abstract][Full Text] [Related]
13. Selection of metastatic variants with identifiable karyotypic changes from a nonmetastatic murine tumor after treatment with 2'-deoxy-5-azacytidine or hydroxyurea: implications for the mechanisms of tumor progression. Frost P; Kerbel RS; Hunt B; Man S; Pathak S Cancer Res; 1987 May; 47(10):2690-5. PubMed ID: 2436755 [TBL] [Abstract][Full Text] [Related]
14. Gene induction and apoptosis in human hepatocellular carci-noma cells SMMC-7721 exposed to 5-aza-2'-deoxycytidine. Fan H; Zhao ZJ; Cheng YC; Shan YF; Lu ZH; Zhang JQ; Xie W Chin Med J (Engl); 2007 Sep; 120(18):1626-31. PubMed ID: 17908484 [TBL] [Abstract][Full Text] [Related]
15. Effect of 5-azacytidine on DNA methylation and the malignant properties of B16 melanoma cells. Trainer DL; Kline T; Mallon F; Greig R; Poste G Cancer Res; 1985 Dec; 45(12 Pt 1):6124-30. PubMed ID: 2415238 [TBL] [Abstract][Full Text] [Related]
16. [Genetic transformation of somatic cells. VIII. The effect of the DNA methylation inhibitor 5-azacytidine on the stability of thymidine kinase-negative and -positive phenotypes of transformant clone cells]. Glebov OK; Abramian DS Tsitologiia; 1985 Jul; 27(7):805-13. PubMed ID: 2413597 [TBL] [Abstract][Full Text] [Related]
17. A method to distinguish between the de novo induction of thymidine kinase mutants and the selection of pre-existing thymidine kinase mutants in the mouse lymphoma assay. Wang J; Heflich RH; Moore MM Mutat Res; 2007 Jan; 626(1-2):185-90. PubMed ID: 17055776 [TBL] [Abstract][Full Text] [Related]
18. Depression of DNA synthesis in mouse spleen after treatment with 5-aza-2'-deoxycytidine. Cihák A; Veselý J J Natl Cancer Inst; 1979 Oct; 63(4):1035-9. PubMed ID: 90150 [TBL] [Abstract][Full Text] [Related]
19. Effects of 5-aza-2'-deoxycytidine on differentiation and oncogene expression in the human monoblastic leukemia cell line U-937. Attadia V Leukemia; 1993 May; 7 Suppl 1():9-16. PubMed ID: 7683359 [TBL] [Abstract][Full Text] [Related]
20. Heritable high frequency modulation of antigen expression in neoplastic cells exposed to 5-aza-2'-deoxycytidine or hydroxyurea: analysis and implications. Alvarez E; Elliott BE; Houghton AN; Kerbel RS Cancer Res; 1988 May; 48(9):2440-5. PubMed ID: 2451561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]